Investment Managers Series Trust II - Tradr 2X Long SNPS Daily ETF

SNPX
31.83
-3.66 (-10.31%)
6:45:31 PM EDT: $31.97 +0.14 (+0.44%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Synaptogenix Inc Stock, :SNPX

1185 Avenue of the Americas, 3rd floor, New York, New York 10036
United States of America
Phone: +1.973.242.0005
Number of Employees: 8
http://www.synaptogen.com

Description

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer�s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson�s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.